Scientific Review of Thiotepa

CASRN 52-24-4
Status: Listed in the Report on Carcinogens (RoC)

Primary Uses or Exposures: Thiotepa is used as a cytostatic agent in the treatment of lymphomas and a variety of solid and soft-tissue tumors.

Background Document

No Public Comments

Meetings

Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, contact Central Data Management or call 919-541-3419 and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.